Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity (Q33231553)

24 July 2017

Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity (English)

1 reference

24 July 2017

Conrad Yap Edosada

1

1 reference

24 July 2017

Clifford Quan

2

1 reference

24 July 2017

Christian Wiesmann

3

1 reference

24 July 2017

Thuy Tran

4

1 reference

24 July 2017

Dan Sutherlin

5

1 reference

24 July 2017

Mark Reynolds

6

1 reference

24 July 2017

J Michael Elliott

7

1 reference

24 July 2017

Helga Raab

8

1 reference

24 July 2017

Wayne Fairbrother

9

1 reference

24 July 2017

Beni B Wolf

10

1 reference

24 July 2017

language of work or name

English

0 references

publication date

12 January 2006

1 reference

Journal of Biological Chemistry

24 July 2017

1 reference

24 July 2017

281

1 reference

24 July 2017

11

1 reference

24 July 2017

7437-7444

1 reference

Tumor-stroma interactions

24 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

The prolyl oligopeptidase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Effect of multiple symmetries on the association of R67 DHFR subunits bearing interfacial complementing mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Boro-norleucine as a P1 residue for the design of selective and potent DPP7 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Solid-phase peptide synthesis and solid-state NMR spectroscopy of [Ala3-15N][Val1]gramicidin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Recent advances in the medicinal chemistry of alpha-aminoboronic acids, amine-carboxyboranes and their derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Genetic relationship between acylpeptide hydrolase and acylase, two hydrolytic enzymes with similar binding but different catalytic specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Synthesis and structure-activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511112200

21 January 2018

Identifiers

DOI

10.1074/JBC.M511112200

1 reference

24 July 2017

1 reference